Next Article in Journal
Inactivation of Anandamide Signaling: A Continuing Debate
Next Article in Special Issue
Echinacea—A Source of Potent Antivirals for Respiratory Virus Infections
Previous Article in Journal
Allosteric Modulation of G Protein Coupled Receptors by Cytoplasmic, Transmembrane and Extracellular Ligands
Open AccessReview

Anti-Viral Drugs for Human Adenoviruses

School of Biomedical Sciences, Croucher Laboratory for Human Genomics, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2010, 3(10), 3343-3354; https://doi.org/10.3390/ph3103343
Received: 2 September 2010 / Revised: 23 October 2010 / Accepted: 25 October 2010 / Published: 25 October 2010
(This article belongs to the Special Issue Antivirals)
There are many stages in the development of a new drug for viral infection and such processes are even further complicated for adenovirus by the fact that there are at least 51 serotypes, forming six distinct groups (A–F), with different degree of infectivity. This review attempts to address the importance of developing pharmaceuticals for adenovirus and also review recent development in drug discovery for adenovirus, including newer strategies such as microRNA approaches. Different drug screening strategies will also be discussed. View Full-Text
Keywords: adenovirus; pharmaceuticals; microRNA adenovirus; pharmaceuticals; microRNA
Show Figures

Figure 1

MDPI and ACS Style

Waye, M.M.Y.; Sing, C.W. Anti-Viral Drugs for Human Adenoviruses. Pharmaceuticals 2010, 3, 3343-3354.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop